Status:
COMPLETED
a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4
Lead Sponsor:
Cooperative Weichteilsarkom Study Group
Collaborating Sponsors:
Deutsche Krebshilfe e.V., Bonn (Germany)
Conditions:
Sarcoma, Soft Tissue
Eligibility:
All Genders
Up to 21 years
Phase:
PHASE2
Brief Summary
Phase II Study to evaluate the response on two blocks of topotecan and carboplatin
Detailed Description
Phase II study for patients with chemosensible soft tissue sarcoma stage IV in children and adolescents ; response according to RECIST criteria following two blocks of combination therapy consisting o...
Eligibility Criteria
Inclusion
- Soft tissue sarcoma chemosensible, stage IV
- age \< 21
- measurable tumor lesions
Exclusion
- Lack of cooperation by the patient
- no willingness of follow-up examinations
- participation on another clinical trial at the same time
- death due to the sickness within four weeks
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2009
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00130858
Start Date
January 1 2005
End Date
March 1 2009
Last Update
April 2 2009
Active Locations (38)
Enter a location and click search to find clinical trials sorted by distance.
1
HELIOS Klinikum Erfurt GmbH
Erfurt, Saxony, Germany, 99089
2
Zentralklinikum
Augsburg, Germany, 86156
3
Klinikum Berlin-Buch
Berlin, Germany, 13125
4
Virchow Klinik
Berlin, Germany, 13353